Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引：0
|
作者：
Pamela C. Heaton
Vibha C. A. Desai
Christina M. L. Kelton
Swapnil N. Rajpathak
机构：
[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy
[2] HealthCore,Carl H. Lindner College of Business
[3] University of Cincinnati,undefined
[4] US Outcomes Research,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
来源：
BMC Endocrine Disorders | / 16卷
关键词：
Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
    Wahlqvist, Mark L.
    Lee, Meei-Shyuan
    Hsu, Chih-Cheng
    Chuang, Shao-Yuan
    Lee, Jiunn-Tay
    Tsai, Hsin-Ni
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (06) : 753 - 758
  • [22] Strategies to Prevent Readmission in High-Risk Patients with Diabetes: the Importance of an Interdisciplinary Approach
    Gregory, Naina Sinha
    Seley, Jane J.
    Dargar, Savira Kochhar
    Galla, Naveen
    Gerber, Linda M.
    Lee, Jennifer I.
    CURRENT DIABETES REPORTS, 2018, 18 (08)
  • [23] Is pain at discharge a risk factor for unplanned hospital readmission?
    Deschepper, Mieke
    Vermeir, Peter
    Vogelaers, Dirk
    Devulder, Jacques
    Eeckloo, Kristof
    ACTA CLINICA BELGICA, 2017, 72 (02) : 95 - 102
  • [24] Predictors of hospital readmission rate in geriatric patients
    Bortolani, Arianna
    Fantin, Francesco
    Giani, Anna
    Zivelonghi, Alessandra
    Pernice, Bruno
    Bortolazzi, Elena
    Urbani, Silvia
    Zoico, Elena
    Micciolo, Rocco
    Zamboni, Mauro
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [25] Predictors of hospital readmission rate in geriatric patients
    Arianna Bortolani
    Francesco Fantin
    Anna Giani
    Alessandra Zivelonghi
    Bruno Pernice
    Elena Bortolazzi
    Silvia Urbani
    Elena Zoico
    Rocco Micciolo
    Mauro Zamboni
    Aging Clinical and Experimental Research, 36
  • [26] Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review
    Chen, Yuehong
    Du, Liang
    Li, Ling
    Ma, Jun
    Geng, Xingyuan
    Yao, Xun
    Liu, Guanjian
    Sun, Xin
    JOURNAL OF DIABETES, 2017, 9 (05) : 482 - 494
  • [27] Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea
    Dworacka, M
    Abramczyk, M
    Winiarska, H
    Kuczynski, S
    Borowska, M
    Szczawinska, K
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (01) : 14 - 21
  • [28] COMBINED THERAPY FOR OBESE TYPE-2 DIABETES - SUPPERTIME MIXED INSULIN WITH DAYTIME SULFONYLUREA
    RIDDLE, M
    HART, J
    BINGHAM, P
    GARRISON, C
    MCDANIEL, P
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 303 (03) : 151 - 156
  • [29] Sulfonylurea use is associated with larger infarct size in patients with diabetes and ST-elevation myocardial infarction
    Abdelmoneim, Ahmed S.
    Welsh, Robert C.
    Eurich, Dean T.
    Simpson, Scot H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 126 - 130
  • [30] HYPOGLYCEMIA AND THE RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN ELDERLY AND SENILE PATIENTS WITH TYPE 2 DIABETES
    Ostrounnova, Olga D.
    Surkova, Elena, V
    Goloborodova, Irina, V
    Starodubova, Antonina, V
    Kochetkov, Alexey, I
    Kiknadze, Tamara D.
    Galstayn, Gagik R.
    DIABETES MELLITUS, 2020, 23 (01): : 72 - 87
12345